Pasireotide Extended-Release Injection and Tapentadol Extended-Release Tablets
Determining the interaction of Pasireotide Extended-Release Injection and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Tapentadol Hydrochloride
- Pasireotide Extended-Release Injection-Tapentadol Tablets
- Pasireotide Extended-Release Injection-TaperDex 12-day
- Pasireotide Extended-Release Injection-TaperDex 6-day
- Pasireotide Extended-Release Injection-TaperDex 7-day
- Pasireotide Extended-Release Injection-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Pasireotide Injection
- Tapentadol Extended-Release Tablets-Pasireotide Subcutaneous
- Tapentadol Extended-Release Tablets-Patanase
- Tapentadol Extended-Release Tablets-Patiromer
- Tapentadol Extended-Release Tablets-Patiromer Sorbitex Calcium
- Tapentadol Extended-Release Tablets-Pavacot